期刊
IMMUNOLOGY AND CELL BIOLOGY
卷 88, 期 6, 页码 624-631出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/icb.2010.53
关键词
human; IL-21; Th9; type I interferons
资金
- NIH [DK082537, F31 CA142272]
- Ben May Trust
- National Science Foundation
- [5 U19 AI050864]
- [1 U19 AI082719]
- [N01-HV-28183]
Interleukin (IL)-9-producing CD4(+) T cells are a novel subset of T helper (Th) cells that develops independently of the Th1, Th2, Th17 and regulatory T-cell lineages. Similar to the murine model, transforming growth factor (TGF)-beta and IL-4 directed human naive CD4(+) T cells to produce IL-9. Whereas IL-4 suppressed TGF-beta-induced Foxp3 expression, TGF-beta failed to inhibit IL-4-mediated upregulation of the Th2 transcription factor GATA-3. Addition of IL-1 beta, IL-6, IL-10, interferon (IFN)-alpha, IFN-beta or IL-21 to Th9-polarizing conditions augmented Th9 differentiation, while the Th1-associated cytokines IFN-gamma and IL-27 partially suppressed IL-9 production. Given that T cells are a primary source of IL-21, IL-21 expression was analyzed under Th9-polarizing conditions in the context of inflammatory cytokines. Surprisingly, type I IFNs induced elevated levels of IL-21, and blockade of IL-21 abrogated their ability to enhance Th9 differentiation. Taken together, these data indicate a complex cytokine network in the regulation of human IL-9-producing CD4(+) T cells. Immunology and Cell Biology (2010) 88, 624-631; doi: 10.1038/icb.2010.53; published online 27 April 2010
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据